New combo attack on tough liver cancer
NCT ID NCT04238637
Summary
This study is testing whether adding immunotherapy drugs to a standard targeted radiation treatment helps control advanced bile duct cancer that starts in the liver. It will involve about 50 adults whose cancer cannot be removed by surgery. Patients will receive the radiation treatment, then be assigned to get one or two immunotherapy drugs to see if the combination is safe and more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinic Essen Center
Essen, Germany
-
Hannover Medical School
Hanover, Germany
-
Munich Clinic Bogenhausen
Munich, Germany
-
University Hospital Dresden
Dresden, Germany
-
University Hospital Essen
Essen, Germany
-
University Hospital Halle
Halle, Germany
-
University Hospital Jena
Jena, Germany
-
University Hospital Munich Grosshadern
Munich, Germany
Conditions
Explore the condition pages connected to this study.